Torley Helen Insider Trading Activity (HALO)

Profile

Helen Torley is the President and CEO of Halozyme Therapeutics, Inc., a biotechnology company specializing in oncology therapies. She has been instrumental in leading the company's strategic direction and development of novel therapeutic products.

Role	PRESIDENT AND CEO, Director
Notability	50/100

Board memberships

Halozyme Therapeutics, Inc.

Awards & honors

Leading Halozyme's growth in oncology therapies
Expanding partnerships with biopharmaceutical companies
Driving innovation in enzyme-based therapies

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-09	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	1.0K	$80.19	$83K
2026-07-09	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	888	$79.28	$70K
2026-07-09	HALO	HALOZYME THERAPEUTICS, INC.	M — Option exercise	1.9K	$12.07	$23K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	6.1K	$69.69	$425K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	2.0K	$68.74	$137K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	1.5K	$67.67	$102K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	400	$66.37	$27K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	M — Option exercise	10.0K	$12.07	$121K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	3.4K	$66.75	$227K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	16.6K	$66.31	$1.10M
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	M — Option exercise	20.0K	$12.07	$241K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	5.4K	$68.35	$369K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	13.0K	$67.41	$876K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	1.6K	$66.39	$107K
2026-06-04	HALO	HALOZYME THERAPEUTICS, INC.	M — Option exercise	20.0K	$12.07	$241K
2026-05-13	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	600	$70.81	$42K
2026-05-13	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	4.0K	$69.79	$276K
2026-05-13	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	3.4K	$68.88	$231K
2026-05-13	HALO	HALOZYME THERAPEUTICS, INC.	S — Open-market sale	2.1K	$68.10	$143K
2026-05-13	HALO	HALOZYME THERAPEUTICS, INC.	M — Option exercise	10.0K	$12.07	$121K

Frequently Asked Questions

Who is Torley Helen?

How many SEC Form 4 filings has Torley Helen submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has Torley Helen been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 83 open-market sales ($37.73M) across all tracked filings.

Where can I see all of Torley Helen's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Torley Helen — SEC Form 4 Insider Trading Activity

Summary